chemotherapy drugs
Sponsors
ARCAGY/ GINECO GROUP, Shenzhen Fifth People's Hospital, Xi'an Jiaotong University, Tianjin Medical University Cancer Institute and Hospital
Conditions
Acute LeukemiaCancer, Therapy-RelatedEndometrial CarcinosarcomaImmune-related Adverse EventMalignant Solid TumorsOvarian CarcinosarcomaPancreatic Cancer ResectableRectal Cancer
Phase 2
Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
RecruitingNCT03651206
Start: 2020-07-15End: 2027-06-30Target: 138Updated: 2025-12-19
Short-Course Radiotherapy Followed by Immunotherapy Combined With Chemotherapy for Microsatellite Stable Locally Advanced Rectal Cancer: A Prospective, Randomized, Controlled Phase II Clinical Trial
RecruitingNCT07594925
Start: 2026-05-01End: 2030-03-01Target: 130Updated: 2026-05-19
Phase 4
The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol
NCT03777930
Start: 2018-12-10End: 2021-06-10Target: 200Updated: 2018-12-19
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
RecruitingNCT06368063
Start: 2024-05-06End: 2028-03-31Target: 642Updated: 2024-05-08